Insider Buying: Dr. Martens (LON:DOCS) Insider Purchases 167 Shares of Stock

Key Points

• Giles Wilson, an insider at Dr. Martens, purchased 167 shares at an average price of GBX 90, totaling £150.30, on September 11th.
• In addition to his latest purchase, he bought 105,838 shares and sold 30,000 shares on September 1st, indicating a significant trading activity.
• Dr. Martens has recently received a "buy" rating from Peel Hunt, while other analysts maintain a mixed stance with an average target price of GBX 6,000.

Dr. Martens plc (LON:DOCS - Get Free Report) insider Giles Wilson purchased 167 shares of Dr. Martens stock in a transaction dated Thursday, September 11th. The shares were bought at an average price of GBX 90 per share, for a total transaction of £150.30.

Giles Wilson also recently made the following trade(s):

• On Monday, September 1st, Giles Wilson purchased 105,838 shares of Dr. Martens stock. The shares were bought at an average price of GBX 91 per share, for a total transaction of £96,312.58.
• On Monday, September 1st, Giles Wilson sold 30,000 shares of Dr. Martens stock. The stock was sold at an average price of GBX 91, for a total value of £27,300.
• On Monday, September 1st, Giles Wilson purchased 30,019 shares of Dr. Martens stock. The shares were bought at an average price of GBX 91 per share, for a total transaction of £27,317.29.
• On Monday, September 1st, Giles Wilson sold 105,785 shares of Dr. Martens stock. The stock was sold at an average price of GBX 90, for a total value of £95,206.50.
• On Monday, August 11th, Giles Wilson purchased 194 shares of Dr. Martens stock. The shares were bought at an average price of GBX 77 per share, for a total transaction of £149.38.
• On Friday, July 11th, Giles Wilson purchased 194 shares of Dr. Martens stock. The shares were bought at an average price of GBX 77 per share, for a total transaction of £149.38.

Dr. Martens Trading Down 2.7%

Shares of LON DOCS traded down GBX 2.55 during trading on Friday, hitting GBX 90.30. 2,855,093 shares of the company were exchanged, compared to its average volume of 2,158,155. Dr. Martens plc has a 12-month low of GBX 43.02 and a 12-month high of GBX 96.50. The company has a debt-to-equity ratio of 127.27, a quick ratio of 1.13 and a current ratio of 2.85. The company has a fifty day moving average price of GBX 84.44 and a 200-day moving average price of GBX 68.86. The firm has a market capitalization of £872.00 million, a PE ratio of 18,060.00, a P/E/G ratio of 6.40 and a beta of 0.11.

Analysts Set New Price Targets

Several research analysts have recently commented on DOCS shares. Peel Hunt upgraded Dr. Martens to a "buy" rating in a report on Monday, August 18th. Deutsche Bank Aktiengesellschaft restated a "hold" rating on shares of Dr. Martens in a report on Friday, July 11th. One research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, Dr. Martens has an average rating of "Hold" and a consensus price target of GBX 6,000.

Dr. Martens Company Profile

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.